Reference number : 236-2014-2015-Q2-00518, amendment number : , agreement type : G, recipient legal name : CHERNEY, David Z, recipient country : CA, recipient province : ON, recipient city : Toronto, recipient postal code : M5G 2C4, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 731520.0, agreement start date : 2014-10-01, agreement end date : 2018-06-30, description english : Blockade of acE and Treatment With Empagliflozin - Effects on hyperfiltratioN in Type 1 Diabetes: The BETWEEN-T1D Study, description french : Blockade of acE and Treatment With Empagliflozin - Effects on hyperfiltratioN in Type 1 Diabetes: The BETWEEN-T1D Study, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2014-15 to 2018-19), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2014-15 à 2018-19), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada